Investors

Presentations & Reports 2018

2020

For investor-related information please contact Ronn Bechler at Automic Group
Ph: +61 (0) 400 009 774 E: ronn.bechler@automicgroup.com.au

Zelda Therapeutics poised to ‘value add al the way from clinical trails to the market’.
Zelda Therapeutics poised to ‘value add all the way from clinical trails to the market’
AGM Presentation – Non-deal Roadshow
AGM Presentation
Zelda enters rapidly-growing German market with product commercialisation strategy
Zelda enters rapidly-growing German market with product commercialisation strategy
Investor Presentation – Non-deal Roadshow
Zelda Therapeutics ready to test ‘entourage effect’ hypothesis in cancer research
Zelda Therapeutics “ahead of the pack”

Zelda Therapeutics “ahead of the pack” in gaining first-mover advantages

Start typing and press Enter to search

Shopping Cart